Click it and Unblock the Notifications
Goldline Pharmaceutical Ltd. IPO
IPO Timeline
-
12 May 2026Bidding Starts
-
14 May 2026Bidding Ends
-
15 May 2026Allotment Finalization
-
19 May 2026Listing
About Goldline Pharmaceutical Ltd.
We are engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” Our product portfolio is organized into five distinct segments: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. The pharmaceutical products marketed under the “Goldline” brand are not manufactured by our Company. Instead, we enter into contractual arrangements with third-party manufacturers, who produce the products based on our market research, demand analysis, and specifications. These contractual arrangements ensure that all products meet the requisite quality standards and regulatory norms.
Goldline Pharmaceutical Ltd. IPO Reservation
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 7,32,000 (27.11%) |
| Market Makers | 1,38,000 (5.11%) |
| Non Institutional Investors | 3,90,000 (14.44%) |
| Qualified Institutional Buyers (QIBs) | 5,40,000 (20%) |
| Retail Individual Investors (RIIs) | 9,00,000 (33.33%) |
Goldline Pharmaceutical Ltd. Financial Information
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2026 | 31.20 Cr | 4.12 Cr | 5.54 Cr |
| 31 Mar 2025 | 28.06 Cr | 2.83 Cr | 1.64 Cr |
| 31 Mar 2024 | 23.57 Cr | 1.80 Cr | 3.76 Cr |
Goldline Pharmaceutical Ltd. Background
-
2004Incorporation of the company as a private company under the name ‘Goldline Pharmaceutical Private Limited.’
-
2013Conversion of our company from a private limited company to a public company and the new name of company as ‘Goldline Pharmaceutical Limited.’
1. Repayment of all or a portion of certain outstanding borrowings availed by our Company
2. General corporate purposes
| Pricing Details | BSE | NSE |
|---|---|---|
| Issue Price | ₹ 43.00 | - |
| Open | ₹ 59.75 | - |
| Low | ₹ 56.77 | - |
| High | ₹ 60.00 | - |
| Last Trade | ₹ 56.77 | - |
1. Amol Laxmikant Mujumdar
2. Swapan Premprakash Khandelwal
The pharmaceutical industry in India is a significant part of the nation's foreign trade and offers lucrative potential for investors. Millions of people around the world receive affordable and inexpensive generic medications from India, which also runs a sizable number ... Read more
Phone no:9970058851
FAQs
When does Goldline Pharmaceutical Ltd. IPO opens and closes?
Goldline Pharmaceutical Ltd. IPO opens from 12th May to 14th May 2026.What is the size of Goldline Pharmaceutical Ltd. IPO?
The size of the Goldline Pharmaceutical Ltd. IPO is ₹11.61 Cr.What is the price range of Goldline Pharmaceutical Ltd. IPO?
The price range of Goldline Pharmaceutical Ltd. IPO is at ₹41 to ₹43 per share.What is the minimum investment and lot size required for the Goldline Pharmaceutical Ltd. IPO?
The minimum investment required is ₹1,29,000 and minimum lot size is 3000 shares.When is Goldline Pharmaceutical Ltd. IPO listing date?
The Goldline Pharmaceutical Ltd. IPO will be listed on 19th May 2026.What is the objective of Goldline Pharmaceutical Ltd. IPO?
1. Repayment of all or a portion of certain outstanding borrowings availed by our Company2. General corporate purposes
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
Sign in with Google